This article was originally published in The Tan Sheet
Three or more daily servings of McNeil Consumer Healthcare's plant stanol product resulted in an average 14% reduction in cholesterol among 14 people participating in a five-week program. Conducted by Mayo Clinic researchers and reported at the American College of Cardiology Scientific Session 2000 in Anaheim, Calif. March 12-15, the cholesterol-reduction challenge involved 46 parents of a class of fifth grade students in Minnesota. Twenty men and women who used at least two-and-a-half servings of Benecol per day saw an average drop in cholesterol of 31.7 mg/dl. Based on a multivariate analysis, Benecol intake was the only variable to correlate "significantly" with a reduction in total serum cholesterol. "If a 1% decline in cholesterol translates into a 2% decline in risk of heart disease, the average participant in this trial experienced a decline in risk [greater than] 17%," the researchers estimate
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC